Verve Therapeutics
VERV
#6830
Rank
A$0.72 B
Marketcap
$8.20
Share price
9.83%
Change (1 day)
-23.38%
Change (1 year)

EPS for Verve Therapeutics (VERV)

EPS in 2023 (TTM): -$4.76

According to Verve Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.95. In 2022 the company made an earnings per share (EPS) of -$4.56 a decrease over its 2021 EPS that were of -$3.95.

EPS history for Verve Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.764.36%
2022-$4.5615.54%
2021-$3.9561.32%
2020-$2.45